HLA supertypes and immune responses to measles–mumps–rubella viral vaccine: Findings and implications for vaccine design
- 20 April 2007
- Vol. 25 (16) , 3090-3100
- https://doi.org/10.1016/j.vaccine.2007.01.020
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Human Leukocyte Antigen Haplotypes in the Genetic Control of Immune Response to Measles‐Mumps‐Rubella VaccineThe Journal of Infectious Diseases, 2006
- Human Leukocyte Antigen Class II Alleles and Rubella‐Specific Humoral and Cell‐Mediated Immunity following Measles‐Mumps‐Rubella–II VaccinationThe Journal of Infectious Diseases, 2005
- The contribution of HLA class I antigens in immune status following two doses of rubella vaccinationHuman Immunology, 2004
- Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISAJournal of Immunological Methods, 2004
- Advantage of rare HLA supertype in HIV disease progressionNature Medicine, 2003
- Frequency of Measles Virus-Specific CD4+and CD8+T Cells in Subjects Seronegative or Highly Seropositive for Measles VaccineClinical and Vaccine Immunology, 2003
- Therapeutics and toxicology: Editorial overviewCurrent Opinion in Pediatrics, 1998
- Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis.Journal of Clinical Investigation, 1997
- Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifsImmunology Today, 1996
- Nomenclature for factors of the HLA system. 1995Tissue Antigens, 1995